SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Tularik Inc. (TLRK)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (334)10/22/2002 4:17:17 PM
From: scaram(o)uche   of 598
 
United States Patent Application 20020151504
Kind Code A1
Huang, Alan ; et al. October 17, 2002

--------------------------------------------------------------------------------
STAT modulators

Abstract
The present invention provides compounds, compositions and methods for the inhibition or treatment of conditions or disorders modulated by the STAT transcription factors, particularly STAT4 and STAT6. Additionally, the compounds are useful for the diagnosis of conditions dependent on STAT signaling.

--------------------------------------------------------------------------------
Inventors: Huang, Alan; (San Mateo, CA) ; Liu, Jiwen; (Belmont, CA) ; Medina, Julio; (San Carlos, CA) ; Wang, Xuemei; (San Bruno, CA) ; Xu, Feng; (Palo Alto, CA) ; Zhu, Liusheng; (Burlingame, CA)
Correspondence Name and Address: TOWNSEND AND TOWNSEND AND CREW, LLP
TWO EMBARCADERO CENTER
EIGHTH FLOOR
SAN FRANCISCO
CA
94111-3834
US


Assignee Name and Adress: Tularik Inc.
Two Corporation Drive
South San Francisco
CA
94080


Serial No.: 008244
Series Code: 10
Filed: November 7, 2001
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext